Cargando…
Intralesional collagenase Clostridium histolyticum vs. verapamil injections in males with Peyronie’s Disease: A prospective, matched-pair, non-blinded, randomised clinical study comparing clinical outcomes and patient satisfaction rates
PURPOSE: To compare clinical outcomes and patient satisfaction rates between intralesional verapamil (ILV) and collagenase Clostridium histolyticum (CCH) injections in males with Peyronie’s disease (PD). MATERIALS AND METHODS: Following ethics approval, PD patients were prospectively enrolled in thi...
Autores principales: | Chung, Eric, Wang, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448666/ https://www.ncbi.nlm.nih.gov/pubmed/36068002 http://dx.doi.org/10.4111/icu.20220145 |
Ejemplares similares
-
Collagenase clostridium histolyticum intralesional injections for the treatment of Peyronie’s disease: a safety profile
por: Yan, Sylvia, et al.
Publicado: (2017) -
Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Levine, Laurence A.
Publicado: (2017) -
Racial variations in response to intralesional collagenase clostridium histolyticum in men with Peyronie’s disease
por: Nguyen, Hoang Minh Tue, et al.
Publicado: (2017) -
Role of collagenase clostridium histolyticum in Peyronie’s disease
por: Peak, Taylor C, et al.
Publicado: (2015) -
Results of SMSNA survey regarding complications following intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
por: Kadioglu, Ates, et al.
Publicado: (2017)